AG2R La Mondiale Gestion d'Actifs’s Gilead Sciences GILD Stock Holding History

AG2R La Mondiale Gestion d'Actifs’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.93M	Buy	54,814 +4,669	+9%	+$615K	0.25%	77
2026 Q1	$6.99M	Buy	50,145 +361	+0.7%	+$50.6K	0.32%	65
2025 Q4	$6.11M	Buy	49,784 +2,652	+6%	+$322K	0.27%	74
2025 Q3	$5.23M	Hold	47,132	–	–	0.27%	73
2025 Q2	$5.23M	Buy	47,132 +804	+2%	+$85.6K	0.27%	73
2025 Q1	$5.1M	Buy	+46,328	New	+$4.78M	0.28%	71

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

AG2R La Mondiale Gestion d'Actifs's GILD Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its Gilead Sciences (GILD) stake by 9.3% in Q2 2026, buying an estimated $615K and bringing the position to 54,814 shares worth $6.93M. The position accounts for 0.25% of the portfolio, ranked #77.

AG2R La Mondiale Gestion d'Actifs first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.99M in Q1 2026. 817 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

AG2R La Mondiale Gestion d'Actifs held 54,814 shares of Gilead Sciences worth $6.93M as of Q2 2026.
AG2R La Mondiale Gestion d'Actifs bought 4,669 Gilead Sciences shares in Q2 2026, an estimated $615K.
Gilead Sciences made up 0.25% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #77 holding.
AG2R La Mondiale Gestion d'Actifs first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
AG2R La Mondiale Gestion d'Actifs's Gilead Sciences position peaked at $6.99M in Q1 2026.
817 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.